Impact of overseas opioid regulations on Indian opioid market

Abstract

We study the spill-over effects of the opioid(oxycontin) ban by the USA during 2010 on the Indian market and establish the presence of reverse California effect. Post creating control and experiment groups in N2B (NON-OPIOID ANALGESICS) and N2A (OPIOID ANALGESICS), we used regression models as OLS and Poisson to understand the impacts of various metrics. We have controlled for competition in the model. We observed a rapid increase in sales volume and revenue of the experimental group. We could discover a similar trend in the distinct SKUs sold post the US regulation. We did delve deeper to figure out the effects of this trend in Rich states vs Poor states and found that lack of regulatory measures in Poor states made them even more vulnerable to this rapid rise. Similarly, a lack of robust monitoring in oral opioids might have led to an increased impact on oral drugs observed.